Bavarian Nordic A/S (BVNRY)
OTCMKTS: BVNRY · Delayed Price · USD
8.30
0.00 (0.00%)
Jul 2, 2024, 2:55 PM EDT - Market closed
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 6.64B DKK in the twelve months ending March 31, 2024, with 62.73% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 831.47M DKK, a -33.59% decrease year-over-year. In the year 2023, Bavarian Nordic had annual revenue of 7.06B DKK with 123.99% growth.
Revenue (ttm)
6.64B DKK
Revenue Growth
+62.73%
P/S Ratio
2.02
Revenue / Employee
4,810,974 DKK
Employees
1,381
Market Cap
1.94B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.06B | 3.91B | 123.99% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | 662.49M | 161.87M | 32.33% |
Dec 31, 2018 | 500.62M | -869.53M | -63.46% |
Dec 31, 2017 | 1.37B | 363.41M | 36.10% |
Dec 31, 2016 | 1.01B | -13.82M | -1.35% |
Dec 31, 2015 | 1.02B | -196.25M | -16.13% |
Dec 31, 2014 | 1.22B | 4.31M | 0.36% |
Dec 31, 2013 | 1.21B | 195.87M | 19.27% |
Dec 31, 2012 | 1.02B | 493.04M | 94.16% |
Dec 31, 2011 | 523.60M | 209.53M | 66.71% |
Dec 31, 2010 | 314.07M | 239.29M | 319.98% |
Dec 31, 2009 | 74.78M | -134.02M | -64.19% |
Dec 31, 2008 | 208.81M | -123.30M | -37.13% |
Dec 31, 2007 | 332.10M | 156.81M | 89.46% |
Dec 31, 2006 | 175.29M | -72.30M | -29.20% |
Dec 31, 2005 | 247.60M | 82.81M | 50.26% |
Dec 31, 2004 | 164.78M | -339.86M | -67.35% |
Dec 31, 2003 | 504.64M | 383.57M | 316.79% |
Dec 31, 2002 | 121.08M | - | - |
Dec 31, 2001 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
BVNRY News
- 3 days ago - Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan - GlobeNewsWire
- 5 days ago - Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa - GlobeNewsWire
- 8 days ago - Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA - GlobeNewsWire
- 16 days ago - Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate - GlobeNewsWire
- 4 weeks ago - Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine - GlobeNewsWire
- 4 weeks ago - Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa - GlobeNewsWire
- 6 weeks ago - Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise - GlobeNewsWire
- 6 weeks ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program - GlobeNewsWire